Three Big Questions for Stage 3 & Patient Engagement
Chilmark Research
JANUARY 17, 2014
For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. How Will the Market Respond?
60 
Let's personalize your content